X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (65614) 65614
Newsletter (2331) 2331
Newspaper Article (333) 333
Magazine Article (216) 216
Book Chapter (206) 206
Dissertation (100) 100
Publication (45) 45
Transcript (38) 38
Conference Proceeding (27) 27
Government Document (18) 18
Web Resource (16) 16
Book Review (13) 13
Book / eBook (10) 10
Reference (10) 10
Streaming Video (8) 8
Report (5) 5
Journal / eJournal (4) 4
Trade Publication Article (4) 4
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43831) 43831
methotrexate (35965) 35965
female (26697) 26697
male (21268) 21268
middle aged (16254) 16254
adult (16220) 16220
methotrexate - therapeutic use (15835) 15835
methotrexate - administration & dosage (14006) 14006
aged (10995) 10995
oncology (9425) 9425
rheumatoid arthritis (8807) 8807
rheumatology (8522) 8522
treatment outcome (8411) 8411
animals (8166) 8166
antineoplastic combined chemotherapy protocols - therapeutic use (7738) 7738
methotrexate - adverse effects (7220) 7220
arthritis, rheumatoid - drug therapy (7161) 7161
chemotherapy (6711) 6711
adolescent (6480) 6480
child (6089) 6089
therapy (5841) 5841
drug therapy, combination (5757) 5757
antirheumatic agents - therapeutic use (5331) 5331
cancer (5235) 5235
methotrexate - pharmacology (5223) 5223
care and treatment (4649) 4649
research (4378) 4378
pharmacology & pharmacy (4278) 4278
arthritis (3855) 3855
cyclophosphamide - administration & dosage (3841) 3841
prognosis (3839) 3839
pregnancy (3759) 3759
retrospective studies (3621) 3621
child, preschool (3608) 3608
time factors (3603) 3603
mice (3475) 3475
rheumatoid-arthritis (3435) 3435
double-blind (3423) 3423
drug therapy (3405) 3405
hematology (3270) 3270
follow-up studies (3135) 3135
combined modality therapy (3090) 3090
immunosuppressive agents - therapeutic use (3049) 3049
rheumatoid factor (2972) 2972
infliximab (2903) 2903
doxorubicin - administration & dosage (2883) 2883
risk factors (2851) 2851
analysis (2814) 2814
medicine & public health (2767) 2767
fluorouracil - administration & dosage (2749) 2749
dose-response relationship, drug (2740) 2740
drug administration schedule (2736) 2736
disease (2628) 2628
breast neoplasms - drug therapy (2601) 2601
patients (2597) 2597
children (2551) 2551
efficacy (2526) 2526
vincristine - administration & dosage (2524) 2524
medicine, general & internal (2522) 2522
etanercept (2509) 2509
cyclophosphamide - therapeutic use (2502) 2502
antineoplastic combined chemotherapy protocols - adverse effects (2488) 2488
rats (2474) 2474
dermatology (2297) 2297
antirheumatic agents - adverse effects (2283) 2283
cisplatin - administration & dosage (2278) 2278
health aspects (2271) 2271
drugs (2256) 2256
remission induction (2240) 2240
cyclophosphamide (2184) 2184
psoriasis (2135) 2135
prospective studies (2132) 2132
aged, 80 and over (2127) 2127
immunology (2124) 2124
severity of illness index (2117) 2117
trial (2059) 2059
pediatrics (2033) 2033
antineoplastic agents - therapeutic use (2024) 2024
diagnosis (2007) 2007
obstetrics & gynecology (1981) 1981
toxicity (1955) 1955
dosage and administration (1943) 1943
surgery (1868) 1868
doxorubicin (1865) 1865
antineoplastic combined chemotherapy protocols - administration & dosage (1855) 1855
young adult (1847) 1847
cisplatin (1845) 1845
medical research (1825) 1825
tumor necrosis factor-alpha - antagonists & inhibitors (1824) 1824
antibodies, monoclonal - therapeutic use (1817) 1817
survival rate (1797) 1797
infant (1791) 1791
psoriasis - drug therapy (1743) 1743
biochemistry & molecular biology (1731) 1731
management (1727) 1727
methotrexate - metabolism (1711) 1711
antirheumatic agents - administration & dosage (1683) 1683
leukemia (1680) 1680
clinical trials as topic (1669) 1669
high-dose methotrexate (1629) 1629
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Gerstein Science - Theses (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
Stacks (1) 1
University Archives - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (61579) 61579
German (1987) 1987
Japanese (1547) 1547
French (1520) 1520
Spanish (632) 632
Russian (625) 625
Chinese (428) 428
Italian (397) 397
Polish (321) 321
Korean (187) 187
Portuguese (147) 147
Dutch (92) 92
Turkish (88) 88
Czech (72) 72
Danish (63) 63
Hungarian (62) 62
Hebrew (36) 36
Norwegian (34) 34
Swedish (30) 30
Bulgarian (23) 23
Croatian (22) 22
Serbian (20) 20
Finnish (17) 17
Slovak (17) 17
Persian (13) 13
Romanian (12) 12
Icelandic (4) 4
Slovenian (4) 4
Ukrainian (4) 4
Arabic (3) 3
Bosnian (2) 2
Greek (2) 2
Lithuanian (2) 2
Breton (1) 1
Estonian (1) 1
Indonesian (1) 1
Kurdish (1) 1
Latin (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Cochrane library, ISSN 1469-493X, 06/2016, Volume 2019, Issue 9, p. CD007102
Background This is the second update of a Cochrane review that was first published in 2009, Issue 1. Gestational trophoblastic neoplasia (GTN) is a rare but... 
Trophoblastic | Drug Administration Schedule | Antineoplastic Agents | Risk | Leucovorin | Dactinomycin | Gestational trophoblastic neoplasia | Randomized Controlled Trials as Topic | Gynaecology | Gynaecological | MISCELLANEOUS GYNAECOLOGICAL CANCER TOPICS | Gestational Trophoblastic Disease | Vitamin B Complex | Case‐Control Studies | Methotrexate | Medicine General & Introductory Medical Sciences | Cohort Studies | Cancer | Vitamin B Complex [administration & dosage] | Methotrexate [administration & dosage; adverse effects] | Humans | Antineoplastic Agents [administration & dosage; adverse effects] | FOLINIC ACID | Case-Control Studies | Leucovorin [administration & dosage] | MEDICINE, GENERAL & INTERNAL | CITROVORUM FACTOR RESCUE | PHASE-II TRIAL | Dactinomycin [administration & dosage; adverse effects] | WEEKLY INTRAMUSCULAR METHOTREXATE | Gestational Trophoblastic Disease [drug therapy] | Female | LOW-DOSE METHOTREXATE | SINGLE-AGENT METHOTREXATE | 5-DAY METHOTREXATE | Pregnancy | DISEASE | ORAL ETOPOSIDE | PULSE ACTINOMYCIN-D | Leucovorin - administration & dosage | Dactinomycin - administration & dosage | Antineoplastic Agents - administration & dosage | Vitamin B Complex - administration & dosage | Methotrexate - adverse effects | Antineoplastic Agents - adverse effects | Dactinomycin - adverse effects | Methotrexate - administration & dosage | Gestational Trophoblastic Disease - drug therapy
Journal Article
Journal Article
by Fleischmann, Roy and Mysler, Eduardo and Hall, Stephen and Kivitz, Alan J and Moots, Robert J and Luo, Zhen and DeMasi, Ryan and Soma, Koshika and Zhang, Richard and Takiya, Liza and Tatulych, Svitlana and Mojcik, Christopher and Krishnaswami, Sriram and Menon, Sujatha and Smolen, Josef S and Adams, Luthando and Ally, Mahmood M and du Plooy, Maria C and Louw, Ingrid C and Nayiager, Savithree and Nel, Christoffel B and Nel, Debra and Reuter, Helmuth and Soloman, Ahmed S and Spargo, Catherine E and Rischmueller, Maureen and Sharma, Shunil D and Will, Robert K and Youssef, Peter P and Arroyo, Caroline and Baes, Rosario P and Dulos, Roger B and Hao, Llewellyn T and Lanzon, Allan E and Lichauco, Juan Javier T and Mangubat, Jill H and Ramiterre, Edgar B and Reyes, Bernadette Heizel M and Tan, Perry P and Choe, Jung-Yoon and Kang, Young Mo and Kwon, Seong Ryul and Lee, Sang-Heon and Lee, Shin-Seok and Yoo, Dae-Hyun and Lin, Hsiao-Yi and Luo, Shue-Fen and Tsai, Shih-Tzu and Tsai, Wen-Chan and Tseng, Jui-Cheng and Wei, Cheng-Chung C and Asavatanabodee, Paijit and Nantiruj, Kanokrat and Nilganuwong, Surasak and Uea-Areewongsa, Parichat and Majstorovic, Ljubinka Bozic and Bacic, Suada Mulic and Batalov, Anastas Z and Georgieva-Slavcheva, Gabriela and Mihailova, Mariyana and Nikolov, Nikolay G and Penev, Dimitar P and Spasov, Yuliy A and Stanimirova, Krasimira and Todorov, Stoyan and Toncheva, Antoaneta R and Yordanova, Nadezhda and Mosterova, Zdenka and Novosad, Libor and Prochazkova, Leona and Stehlikova, Helena and Stejfova, Zuzana and Kiseleva, Natalia and Pank, Lea and Savi, Triin and Alexandra, Balbir-Gurman and Amital, Howard and Mevorach, Dror and Rosner, Itzhak A and Mihailova, Anna and Stumbra-Stumberga, Evija and Basijokiene, Vida and Lietuvininkiene, Virginija and Unikiene, Dalia and Brzezicki, Jan and Dudek, Anna M and Glowacka-Kulesz, Maria B and Grabowicz-Wasko, Barbara and Hajduk-Kubacka, Sabina and Hilt, Joanna and Hrycaj, Pawel and Jeka, Slawomir and Kolasa, Renata and Krogulec, Marek and Mastalerz, Hanna and Olak-Popko, Anna and Owczarek, Elzbieta and Ruzga, Zofia and Walczak, Alina and Ancuta, Codrina I and ... and ORAL Strategy investigators and ORAL Strategy Investigators
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article